FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996811700> ?p ?o ?g. }

• W1996811700 endingPage "90" @default.
• W1996811700 startingPage "77" @default.
• W1996811700 abstract "Misonidazole is a metabolically active drug. Its addition to cells causes an immediate alteration in cellular electron transfer pathways. Under aerobic conditions the metabolic alterations can result in futile cycling with electron transfer to oxygen and production of peroxide. Thiol levels are extremely important in protecting the cell against the peroxide formation and potentially hazardous conditions for hydroxyl radical production. Nevertheless such electron shunting out of cellular metabolism will result in alterations in pentose cycle, glycolysis and cellular capacity to reduce metabolites to essential intermediates needed in DNA metabolism (i.e. deoxyribonucleotides). Glutathione must be depleted to very low levels before toxic effects of misonidazole and other nitro compounds are manifested in cell death via peroxidative damage. Under hypoxic conditions misonidazole also diverts the pentose cycle via its own reduction; however, unlike the aerobic conditions, there are a number of reductive intermediates produced that react with non-protein thiols such as GSH as well as protein thiols. The reaction with protein thiols results in the inhibition of glycolysis and other as yet undetermined enzyme systems. The consequences of the hypoxic pretreatment of cells with nitro compounds are increased vulnerability to radiation and chemotherapeutic drugs such as L-PAM, cis-platinum and bleomycin. The role that altered enzyme activity has in the cellular response to misonidazole and chemotherapeutic agents remains to be determined. It is also clear that the GSH depleted state not only makes cells more vulnerable to oxidative stress but also to hypoxic intermediates produced by the reduction of misonidazole beyond the one electron stage. The relevancy of the present work to the proposed use of thiol depletion in vivo to enhance the radiation or chemotherapeutic response of tumor tissue lies with the following considerations. Apparently, spontaneous peroxidative damage to normal tissue such as liver can occur with GSH depletion to 10-20% of control and with other normal tissue when GSH reaches 50% of control. This situation can obviously become more critical if peroxide producing drugs are administered. The only advantage to such combined drug treatments would lie in the possibility that tumors vary in their catalase and peroxidase activity and consequently may be more vulnerable to oxidative stress (cf. review by Meister. Our tumor model, the A549 human lung carcinoma cell in vitro, appears to be an exception because it has catalase, peroxidase and a high content of GSH.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W1996811700 created "2016-06-24" @default.
• W1996811700 creator A5006011143 @default.
• W1996811700 creator A5011597168 @default.
• W1996811700 creator A5021450037 @default.
• W1996811700 creator A5023874847 @default.
• W1996811700 creator A5030982520 @default.
• W1996811700 creator A5043738756 @default.
• W1996811700 creator A5087969575 @default.
• W1996811700 date "1986-01-01" @default.
• W1996811700 modified "2023-10-18" @default.
• W1996811700 title "Biochemistry of reduction of nitro heterocycles" @default.
• W1996811700 cites W139726096 @default.
• W1996811700 cites W1588147287 @default.
• W1996811700 cites W1964181128 @default.
• W1996811700 cites W1967912912 @default.
• W1996811700 cites W1974179451 @default.
• W1996811700 cites W1975902843 @default.
• W1996811700 cites W1983002920 @default.
• W1996811700 cites W1994498894 @default.
• W1996811700 cites W2020803654 @default.
• W1996811700 cites W2040577258 @default.
• W1996811700 cites W2044689050 @default.
• W1996811700 cites W2047860278 @default.
• W1996811700 cites W2050806091 @default.
• W1996811700 cites W2052889661 @default.
• W1996811700 cites W2053527204 @default.
• W1996811700 cites W2054662394 @default.
• W1996811700 cites W2056659011 @default.
• W1996811700 cites W2056664224 @default.
• W1996811700 cites W2068704847 @default.
• W1996811700 cites W2070912479 @default.
• W1996811700 cites W2078575280 @default.
• W1996811700 cites W2080585635 @default.
• W1996811700 cites W2080824726 @default.
• W1996811700 cites W2085716533 @default.
• W1996811700 cites W2134943429 @default.
• W1996811700 cites W2298949747 @default.
• W1996811700 cites W4299606238 @default.
• W1996811700 doi "https://doi.org/10.1016/0006-2952(86)90561-7" @default.
• W1996811700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2934068" @default.
• W1996811700 hasPublicationYear "1986" @default.
• W1996811700 type Work @default.
• W1996811700 sameAs 1996811700 @default.
• W1996811700 citedByCount "99" @default.
• W1996811700 countsByYear W19968117002012 @default.
• W1996811700 countsByYear W19968117002013 @default.
• W1996811700 countsByYear W19968117002014 @default.
• W1996811700 countsByYear W19968117002015 @default.
• W1996811700 countsByYear W19968117002016 @default.
• W1996811700 countsByYear W19968117002017 @default.
• W1996811700 countsByYear W19968117002020 @default.
• W1996811700 countsByYear W19968117002021 @default.
• W1996811700 countsByYear W19968117002022 @default.
• W1996811700 countsByYear W19968117002023 @default.
• W1996811700 crossrefType "journal-article" @default.
• W1996811700 hasAuthorship W1996811700A5006011143 @default.
• W1996811700 hasAuthorship W1996811700A5011597168 @default.
• W1996811700 hasAuthorship W1996811700A5021450037 @default.
• W1996811700 hasAuthorship W1996811700A5023874847 @default.
• W1996811700 hasAuthorship W1996811700A5030982520 @default.
• W1996811700 hasAuthorship W1996811700A5043738756 @default.
• W1996811700 hasAuthorship W1996811700A5087969575 @default.
• W1996811700 hasConcept C181199279 @default.
• W1996811700 hasConcept C185592680 @default.
• W1996811700 hasConcept C20251656 @default.
• W1996811700 hasConcept C202751555 @default.
• W1996811700 hasConcept C2781305896 @default.
• W1996811700 hasConcept C2781324293 @default.
• W1996811700 hasConcept C3409486 @default.
• W1996811700 hasConcept C538909803 @default.
• W1996811700 hasConcept C55493867 @default.
• W1996811700 hasConcept C62231903 @default.
• W1996811700 hasConceptScore W1996811700C181199279 @default.
• W1996811700 hasConceptScore W1996811700C185592680 @default.
• W1996811700 hasConceptScore W1996811700C20251656 @default.
• W1996811700 hasConceptScore W1996811700C202751555 @default.
• W1996811700 hasConceptScore W1996811700C2781305896 @default.
• W1996811700 hasConceptScore W1996811700C2781324293 @default.
• W1996811700 hasConceptScore W1996811700C3409486 @default.
• W1996811700 hasConceptScore W1996811700C538909803 @default.
• W1996811700 hasConceptScore W1996811700C55493867 @default.
• W1996811700 hasConceptScore W1996811700C62231903 @default.
• W1996811700 hasIssue "1" @default.
• W1996811700 hasLocation W19968117001 @default.
• W1996811700 hasLocation W19968117002 @default.
• W1996811700 hasOpenAccess W1996811700 @default.
• W1996811700 hasPrimaryLocation W19968117001 @default.
• W1996811700 hasRelatedWork W1547091325 @default.
• W1996811700 hasRelatedWork W1982325401 @default.
• W1996811700 hasRelatedWork W2017175132 @default.
• W1996811700 hasRelatedWork W2024452437 @default.
• W1996811700 hasRelatedWork W2049977741 @default.
• W1996811700 hasRelatedWork W2084021943 @default.
• W1996811700 hasRelatedWork W3207659096 @default.
• W1996811700 hasRelatedWork W4285114920 @default.
• W1996811700 hasRelatedWork W432184291 @default.
• W1996811700 hasRelatedWork W81342328 @default.

• next